Netherlands· NL-b5906626b714
Toctino 30 mg, capsules, zacht
A alitretinoin product containing alitretinoïne, registered in Netherlands by Stiefel Laboratories Legacy (Ireland) Limited, Unit 2. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Alitretinoin is registered in 8 of 19 countries.
Countries holding a registration under ATC D11AH04 (alitretinoin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Alitretinoin · ATC D11AH04
8 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of alitretinoin costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Alitretinoin · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$17.29
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- ALITRETINOÏNE
- Manufacturer
- Stiefel Laboratories Legacy (Ireland) Limited, Unit 2
- Country
- Netherlands (NL)
- ATC code
- D11AH04
- ATC class
- Alitretinoin
- Defined daily dose
- 20 mg, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id100962
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
5 interactions on record for alitretinoin.
Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Alitretinoin · interactions on record
5 records
- 1 severe
- 4 moderate
Most severe, free to view
- Aminolevulinic acidL01XD04severe
- Salicylic acidD01AE12moderate
- Porfimer sodiumL01XD01moderate
- MethoxsalenL01XD10moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Alitretinoin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAlitretinoin 30mg capsulesA A H Pharmaceuticals Ltd
- SwitzerlandAlitretinoin Leman
- CanadaHANZEMADR. REDDY'S LABORATORIES INC
- SwedenAlitretinoin Ebb 10 mg Kapsel, mjukEbb Medical AB
- NorwayAlitretinoin OrifarmOrifarm Generics A/S
- FinlandAlitretinoin OrifarmOrifarm Generics A/S
- SpainALITRETINOINA IFC 10 MG CAPSULAS BLANDAS EFGIndustrial Farmaceutica Cantabria S.A.
- FranceALIZEM 10 mg, capsule mollePIERRE FABRE MEDICAMENT
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Alitretan, Toctino
- Belgium · Alitretinoin Orifarm
- Germany · Alitrederm, Toctino
- Denmark · Alitretinoin Orifarm, Toctino
- Spain · Alitretinoína Ifc, Toctino
- Finland · Alitretinoin Orifarm, Toctino
- France · Alizem, Toctino
- United Kingdom (Northern Ireland) · Alitretinoin Ennogen Healthcare, Alitretinoin Ennogen Ip
- Italy · Alitrecare, Toctino
- Norway · Alitretinoin Orifarm, Toctino
- Portugal · Alitretinoína Cantabria
- Sweden · Alitretinoin Orifarm
- Slovenia · Toctino
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f94aa970-925b-49a8-8cfe-3fe47415fc56 GET /v1/drugs/f94aa970-925b-49a8-8cfe-3fe47415fc56?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, zacht",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h100962_smpc.pdf",
"strength": null,
"atc_label": "Alitretinoin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg100962",
"excipients": [
"GELATINE (E 441)",
"GELE OF WITTE WAS (E901)",
"GLYCEROL (E 422)",
"IJZEROXIDE GEEL (E 172)",
"IJZEROXIDE ROOD (E 172)",
"SOJABOONOLIE, GEDEELTELIJK GEHYDREERD (E 479b)",
"SOJAOLIE, GEZUIVERD",
"SORBITOL, VLOEIBAAR, NIET-KRISTALLISEERBAAR (E 420)",
"TOCOFEROL, DL-ALFA (E 307)",
"TRIGLYCERIDEN MIDDELLANGE KETEN",
"WATER, GEZUIVERD"
],
"substances": [
"ALITRETINOÏNE"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h100962.pdf",
"authorised_at": "2009/04/14",
"procedure_number": "DK/H/1377/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "100962",
"additional_monitoring": "N"
}See everything about alitretinoin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.